Abstract
Prodromal unstable angina on presentation is a significant predictor of smaller infarct size, reflected by smaller creatine kinase-MB and creatine kinase total measurements and lower 30-day, 6-month, and 5-year mortality. These findings suggest that prodromal unstable angina is an important physiologic marker that should be routinely collected for risk stratification.
MeSH terms
-
Angina, Unstable / complications*
-
Angina, Unstable / diagnosis*
-
Biomarkers / blood
-
Chi-Square Distribution
-
Creatine Kinase / blood
-
Creatine Kinase, MB Form
-
Female
-
Fibrinolytic Agents / therapeutic use
-
Humans
-
Isoenzymes / blood
-
Logistic Models
-
Male
-
Multivariate Analysis
-
Myocardial Infarction / diagnosis
-
Myocardial Infarction / drug therapy
-
Myocardial Infarction / etiology*
-
Myocardial Infarction / mortality*
-
Predictive Value of Tests
-
Prognosis
-
Prospective Studies
-
Risk Assessment / methods
-
Risk Assessment / standards
-
Risk Factors
-
Survival Analysis
-
Time Factors
-
Tissue Plasminogen Activator / therapeutic use
-
Treatment Outcome
Substances
-
Biomarkers
-
Fibrinolytic Agents
-
Isoenzymes
-
Creatine Kinase
-
Creatine Kinase, MB Form
-
Tissue Plasminogen Activator